A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients

Clinical trial NCT06879717 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06879717
Sponsor: iOnctura
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Advanced Non Squamous NSCLC

Start date: 2025-04-22
Primary completion: 2027-01-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.